Stelios Pharmaceuticals LLP
Winner of India 5000 Best MSME Awards 2024

Details

Registered Company Name
Stelios Pharmaceuticals LLP

Registration Type
Limited Liability Partnership

Business Category
Pharmaceuticals

Business Sub Category
--

website
https://steliospharmaceuticals.com/

Establishment Year
2012

Number Of Employee
21

District
Mumbai City

City & PinCode
Mumbai - 400064

State
Maharashtra

Introduction

Stelios Pharmaceuticals LLP was founded on May 10, 2012, by Mr. Venkateswaran Kailasam Kalpathy and Mrs. Vasanthi Venkateswaran. The roots of Stelios trace back to 1958, when Mr. Venkateswaran’s father, the late K.V. Kailasam, joined a major pharmaceutical firm to gain insights into the industry. Inspired by his early exposure to the world of pharmaceuticals, Mr. Venkateswaran began his own career on July 13, 1987, building an impressive 37 years of experience across various esteemed roles in the field. Guided by the values instilled by his parents, particularly his mother, Mrs. Parvathy Kailasam, whose commitment to quality healthcare greatly influenced him, Stelios Pharmaceuticals is driven by a mission to improve lives. The company is dedicated to "Adding Smiles to Life" and has established a reputation in the healthcare sector by delivering unique products with uncompromising ethical standards.

Stelios Pharmaceuticals LLP operates extensively across India, with a notable presence in Maharashtra and Tamil Nadu, ensuring a robust distribution network that reaches healthcare markets nationwide. The company prides itself on a highly trained, dedicated team that provides exceptional service to its targeted customers, with team members considered to be the company’s most valuable asset. Leveraging this expertise has enabled Stelios to navigate challenges and strengthen its position in the healthcare sector. Serving all segments of the healthcare industry, Stelios offers a diverse range of products that meet the varied needs of healthcare specialists in treating patients effectively.

Manufactured in a state-of-the-art facility certified by WHO-GMP, Stelios Pharmaceuticals offers a comprehensive selection of products known for their high quality. The range includes antioxidants, anti-inflammatories, cough syrups, pain relievers, anti-malarials, anti-allergics, medications for acid reflux, calcium supplements, as well as products for cardiac and diabetic care. These offerings cater to a broad array of healthcare needs, reflecting Stelios’ commitment to quality and patient care.

Stelios Pharmaceuticals also prioritizes corporate social responsibility. The company regularly donates medicines to trust hospital pharmacies, ensuring that underprivileged patients have access to essential medications at no cost. Stelios supports education by providing free education opportunities to those in need and also assists the elderly through financial contributions and free medicines. The company actively promotes physical wellness by sponsoring sports events and encouraging outdoor activities. During the COVID-19 pandemic, Stelios Pharmaceuticals ensured that its employees were fully supported, maintaining uninterrupted salary payments and providing insurance coverage of ₹5 lakhs per employee. In addition to employee welfare, Stelios distributed sanitizers, groceries, and essential items to those in need, including domestic workers and drivers, and made a contribution to the PM CARES Fund.

The company’s commitment to community support was further exemplified by its assistance to Mr. Mohammed Khadar Rangari, known as Raja, an auto driver struggling during the pandemic. Stelios Pharmaceuticals paid off his outstanding auto loan, enabling him to regain his vehicle and continue supporting his family. Through initiatives like these, Stelios Pharmaceuticals upholds a tradition of compassion, service, and dedication to social well-being.

CEO Details

Mr. Venkateswaran Kailasam Kalpathy
B.Sc, PGDMSM, M.B.A

Mr. Venkateswaran Kailasam Kalpathy, CEO of Stelios Pharmaceuticals LLP, possesses a wealth of over 37 years of experience in the pharmaceutical industry, having worked across India in a variety of roles. His career began on July 13, 1987, as a Medical Representative with Rallis India Limited, a Tata enterprise, in Faizabad, Uttar Pradesh. From there, he advanced through various reputable companies, gaining experience that would eventually inspire him to establish Stelios Pharmaceuticals on May 10, 2012.

With a strong commitment to excellence, Mr. Venkateswaran has led Stelios from its beginnings as a startup to its current status as a respected name in the industry. Known for his hands-on leadership style, he brings an unparalleled level of energy and enthusiasm to his work, actively guiding his team at 58 with the same vigor as his younger counterparts. His keen understanding of market trends and ability to make strategic, well-informed decisions have allowed him to navigate challenges and leverage opportunities effectively. This visionary approach, paired with a relentless commitment to quality, has driven Stelios toward consistent growth and a widening presence in the healthcare market.

Mr. Venkateswaran’s ultimate vision for Stelios is to transform it into a ₹100 crore company by 2030. Together with his team, he is focused on making healthcare affordable and accessible, delivering products that meet essential needs across India. His drive, strategic insight, and dedication to societal impact have not only propelled Stelios’ success but have also fostered a mission-oriented culture within the company, working to improve healthcare accessibility for all. With a focus on sustainable growth and a commitment to excellence, Mr. Venkateswaran is shaping Stelios Pharmaceuticals LLP into a leading force in Indian healthcare.

Share this page